SCHEMBL14195568

SCHEMBL14195568

COc1ccc(Cn2c(-c3ccncc3)nnc2S(C)(=O)=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ PDE5A O76074 1/20 0.51
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ MAPT P10636 2/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ GFER P55789 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ HTT P42858 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ CNR2 P34972 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ LSS P48449 1/20 0.42
▸ PTGS2 P35354 1/20 0.41
▸ BCHE P06276 1/20 0.41
▸ TP53 P04637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14195569 0.80 CYP3A4 (0.56) TSHRCYP3A4PDE5AKDM4EALDH1A1
SCHEMBL11920072 0.79 OXTR (0.51) CYP3A4ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL14195584 0.78 TSHR (0.63) TSHRCYP3A4PDE5AKDM4EALDH1A1
SCHEMBL7519882 0.77 TSHR (0.53) TSHRCYP3A4PDE5AKDM4EALDH1A1
SCHEMBL13446882 0.76 CYP1A2 (0.54) TSHRKDM4EALDH1A1MAPTGAA
SCHEMBL14195583 0.75 KDM4E (0.52) TSHRCYP3A4PDE5AKDM4EALDH1A1
SCHEMBL1544452 0.72 ALDH1A1 (0.43) TSHRCYP3A4KDM4EALDH1A1MAPT
SCHEMBL7512001 0.70 QPCTL (0.58) TSHRCYP3A4PDE5AKDM4EALDH1A1
SCHEMBL10288359 0.70 PDE5A (0.59) TSHRCYP3A4PDE5AKDM4EALDH1A1
SCHEMBL23063346 0.68 KDM4E (0.48) KDM4EALDH1A1MAPTALOX15GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7361669-B2 Compositions and method for inhibiting TGF-β MILLENNIUM PHARMACEUTICALS, INC. (US) 2008-04-22 — — US disclosed
Send feedback